Reduced-dose #NOACs as well as aspirin alone were noninferior to #DAPT for a composite of adverse clinical outcomes through six months following LAAC, according to results from the SIMPLAAFY trial presented at #TCT2026.
Read more: https://bit.ly/4AdRF0h #CardioSky
Read more: https://bit.ly/4AdRF0h #CardioSky
November 2, 2026 at 7:51 PM
This supports my scepticism towards the focus on ECG changes in the OMI paradigm.
Every patient with suspected AMI and persisting symptoms (and/or ECG changes) should get an immediate echo!
#cardiosky #emsky #emimcc
Every patient with suspected AMI and persisting symptoms (and/or ECG changes) should get an immediate echo!
#cardiosky #emsky #emimcc
New abstract by EKHUFT colleagues:
"Prevalence and outcome of occluded coronary arteries in non-ST-segment elevation myocardial infarction patients in a high-volume primary percutaneous coronary intervention centre"
Open-access available here: academic.oup.com/eurheartj/ar...
"Prevalence and outcome of occluded coronary arteries in non-ST-segment elevation myocardial infarction patients in a high-volume primary percutaneous coronary intervention centre"
Open-access available here: academic.oup.com/eurheartj/ar...
Prevalence and outcome of occluded coronary arteries in non-ST-segment elevation myocardial infarction patients in a high-volume primary percutaneous coronary intervention centre
AbstractBackground. Conventional electrocardiogram (ECG) changes, such as ST elevation (STEMI) or non-ST elevation (NSTEMI), have long been the cornerstone
academic.oup.com
November 2, 2026 at 8:00 PM
This supports my scepticism towards the focus on ECG changes in the OMI paradigm.
Every patient with suspected AMI and persisting symptoms (and/or ECG changes) should get an immediate echo!
#cardiosky #emsky #emimcc
Every patient with suspected AMI and persisting symptoms (and/or ECG changes) should get an immediate echo!
#cardiosky #emsky #emimcc
Why do a watchman for fall risk ? Are you any better off falling on Asa than falling on eliquis? Is it helpful to crash a car at 60 mph instead of 65? #cardiosky
November 3, 2026 at 1:48 PM
Why do a watchman for fall risk ? Are you any better off falling on Asa than falling on eliquis? Is it helpful to crash a car at 60 mph instead of 65? #cardiosky
🆕 challenging cases presented at #TCT2026 & simultaneously published across the #JACCJournals offer insights into key questions & challenging scenarios in interventional cardiology.
Read highlights from a selection of cases 👉 https://bit.ly/4A4utBk
#JACCCaseReports #CardioSky
Read highlights from a selection of cases 👉 https://bit.ly/4A4utBk
#JACCCaseReports #CardioSky
November 3, 2026 at 4:00 PM
🆕 challenging cases presented at #TCT2026 & simultaneously published across the #JACCJournals offer insights into key questions & challenging scenarios in interventional cardiology.
Read highlights from a selection of cases 👉 https://bit.ly/4A4utBk
#JACCCaseReports #CardioSky
Read highlights from a selection of cases 👉 https://bit.ly/4A4utBk
#JACCCaseReports #CardioSky
SINGLE-CLOSURE: A single-ProGlide strategy may be noninferior for a composite of access-site or access-related vascular complications compared to conventional double-ProGlide closure following transfemoral #TAVR.
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
November 3, 2026 at 8:09 PM
SINGLE-CLOSURE: A single-ProGlide strategy may be noninferior for a composite of access-site or access-related vascular complications compared to conventional double-ProGlide closure following transfemoral #TAVR.
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
This is the data I've been waiting for, finally a comparison of mechanical thrombectomy vs our standard of care, anticoagulation, for intermediate-high risk pulmonary embolism on long term functional outcomes. I'm starting to be convinced it's worth it. #cardiosky #emimcc
Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-High Risk PE: Improved Functional 90-Day Outcomes in STORM-PE RCT
www.jacc.org
November 4, 2026 at 10:11 PM
This is the data I've been waiting for, finally a comparison of mechanical thrombectomy vs our standard of care, anticoagulation, for intermediate-high risk pulmonary embolism on long term functional outcomes. I'm starting to be convinced it's worth it. #cardiosky #emimcc
ICYMI: 🔑 Key findings from #TCT2026 LBCTs
P4: A CCTA-guided #PCI strategy was noninferior to IVUS–guided PCI for target-vessel failure at 12 months.
TRANSFORM II: Sirolimus-coated balloon was noninferior to EES in native coronary arteries.
🔗 https://bit.ly/3W5NViJ #CardioSky
P4: A CCTA-guided #PCI strategy was noninferior to IVUS–guided PCI for target-vessel failure at 12 months.
TRANSFORM II: Sirolimus-coated balloon was noninferior to EES in native coronary arteries.
🔗 https://bit.ly/3W5NViJ #CardioSky
November 2, 2026 at 3:47 PM
ICYMI: 🔑 Key findings from #TCT2026 LBCTs
P4: A CCTA-guided #PCI strategy was noninferior to IVUS–guided PCI for target-vessel failure at 12 months.
TRANSFORM II: Sirolimus-coated balloon was noninferior to EES in native coronary arteries.
🔗 https://bit.ly/3W5NViJ #CardioSky
P4: A CCTA-guided #PCI strategy was noninferior to IVUS–guided PCI for target-vessel failure at 12 months.
TRANSFORM II: Sirolimus-coated balloon was noninferior to EES in native coronary arteries.
🔗 https://bit.ly/3W5NViJ #CardioSky
What does SIRONA tell us about sirolimus- vs. paclitaxel-coated balloon angioplasty at 3 years?
🎥 Hear from Ulf Teichgräber, MD, and Sahil Parikh, MD, FACC, in this #ACCAnywhere TV Quick Take from #TCT2026.
🔗 https://bit.ly/4BA3VcN
#JACCINT #CardioSky @crfheart.bsky.social
🎥 Hear from Ulf Teichgräber, MD, and Sahil Parikh, MD, FACC, in this #ACCAnywhere TV Quick Take from #TCT2026.
🔗 https://bit.ly/4BA3VcN
#JACCINT #CardioSky @crfheart.bsky.social
November 3, 2026 at 7:45 PM
What does SIRONA tell us about sirolimus- vs. paclitaxel-coated balloon angioplasty at 3 years?
🎥 Hear from Ulf Teichgräber, MD, and Sahil Parikh, MD, FACC, in this #ACCAnywhere TV Quick Take from #TCT2026.
🔗 https://bit.ly/4BA3VcN
#JACCINT #CardioSky @crfheart.bsky.social
🎥 Hear from Ulf Teichgräber, MD, and Sahil Parikh, MD, FACC, in this #ACCAnywhere TV Quick Take from #TCT2026.
🔗 https://bit.ly/4BA3VcN
#JACCINT #CardioSky @crfheart.bsky.social
TomorrowLAND: Prolonged perfusion balloon predilation & intracoronary delivery of Nicorandil with the Rx Ryusei perfusion balloon did not significantly reduce slow-flow or no-reflow in patients presenting with #STEMI undergoing primary #PCI.
↪️ https://bit.ly/4zZPblO
#TCT2026 #CardioSky
↪️ https://bit.ly/4zZPblO
#TCT2026 #CardioSky
November 3, 2026 at 12:11 AM
TomorrowLAND: Prolonged perfusion balloon predilation & intracoronary delivery of Nicorandil with the Rx Ryusei perfusion balloon did not significantly reduce slow-flow or no-reflow in patients presenting with #STEMI undergoing primary #PCI.
↪️ https://bit.ly/4zZPblO
#TCT2026 #CardioSky
↪️ https://bit.ly/4zZPblO
#TCT2026 #CardioSky
Jetzt für die AGIK #TAVI Akademie anmelden! Machen Sie sich verschiedenen TAVI-Systemen vertraut! Der Kurs der #DGKAkadmie kombiniert theoretisches Wissen mit umfangreichen praktischen Übungen an Simulatoren.
➡️ Mehr Infos:
herzmedizin.de/fuer-...
#DGK #Kardiologie #CardioSky
➡️ Mehr Infos:
herzmedizin.de/fuer-...
#DGK #Kardiologie #CardioSky
November 4, 2026 at 6:01 AM
Jetzt für die AGIK #TAVI Akademie anmelden! Machen Sie sich verschiedenen TAVI-Systemen vertraut! Der Kurs der #DGKAkadmie kombiniert theoretisches Wissen mit umfangreichen praktischen Übungen an Simulatoren.
➡️ Mehr Infos:
herzmedizin.de/fuer-...
#DGK #Kardiologie #CardioSky
➡️ Mehr Infos:
herzmedizin.de/fuer-...
#DGK #Kardiologie #CardioSky
ICYMI: Dive into the latest paper published in #JACC that reveals how #CVD mortality varies dramatically across U.S. counties, racial & ethnic groups, & specific CV conditions.
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
October 31, 2026 at 9:24 PM
ICYMI: Dive into the latest paper published in #JACC that reveals how #CVD mortality varies dramatically across U.S. counties, racial & ethnic groups, & specific CV conditions.
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
📄 „Impfen ist ❤️-Sache“: Jetzt kostenlos das Praxis-Kit #Prävention & Impfschutz vorbestellen! Unterstützen Sie Ihre Patienten mit verständlichen Materialien rund um Impfungen bei Herzerkrankungen.
➡️ herzmedizin.de/fuer-aerzte-...
#NationeHerzAllianz #Kardiologie #CardioSky
➡️ herzmedizin.de/fuer-aerzte-...
#NationeHerzAllianz #Kardiologie #CardioSky
Bestellformular Praxis-Kit
Bestellen Sie über das Formular ein Praxis-Kit mit Informationen für Ihre Patientinnen und Patienten.
herzmedizin.de
November 5, 2026 at 1:44 PM
📄 „Impfen ist ❤️-Sache“: Jetzt kostenlos das Praxis-Kit #Prävention & Impfschutz vorbestellen! Unterstützen Sie Ihre Patienten mit verständlichen Materialien rund um Impfungen bei Herzerkrankungen.
➡️ herzmedizin.de/fuer-aerzte-...
#NationeHerzAllianz #Kardiologie #CardioSky
➡️ herzmedizin.de/fuer-aerzte-...
#NationeHerzAllianz #Kardiologie #CardioSky
Reduced-dose #NOACs as well as aspirin alone were noninferior to #DAPT for a composite of adverse clinical outcomes through six months following LAAC, according to results from the SIMPLAAFY trial presented at #TCT2026.
Read more: https://bit.ly/4AdRF0h #CardioSky
Read more: https://bit.ly/4AdRF0h #CardioSky
November 2, 2026 at 7:16 PM
Reduced-dose #NOACs as well as aspirin alone were noninferior to #DAPT for a composite of adverse clinical outcomes through six months following LAAC, according to results from the SIMPLAAFY trial presented at #TCT2026.
Read more: https://bit.ly/4AdRF0h #CardioSky
Read more: https://bit.ly/4AdRF0h #CardioSky
DUOTAP: Routine postdilation with a balloon-expandable transcatheter heart valve (THV) optimized THV geometry and improved hemodynamic performance, without increasing procedure-related adverse events in patients with severe aortic stenosis.
🔗 https://bit.ly/4BJgHWz #TCT2026 #CardioSky
🔗 https://bit.ly/4BJgHWz #TCT2026 #CardioSky
November 3, 2026 at 10:15 PM
DUOTAP: Routine postdilation with a balloon-expandable transcatheter heart valve (THV) optimized THV geometry and improved hemodynamic performance, without increasing procedure-related adverse events in patients with severe aortic stenosis.
🔗 https://bit.ly/4BJgHWz #TCT2026 #CardioSky
🔗 https://bit.ly/4BJgHWz #TCT2026 #CardioSky
ENCIRCLE: Patients with symptomatic mitral regurgitation (MR) who underwent full percutaneous transseptal #TMVR continued to see durable near #vhdMR elimination & sustained improvements in functional & health status outcomes at 2 years. https://bit.ly/4z2BMIW
#JACC #CardioSky @crfheart.bsky.social
#JACC #CardioSky @crfheart.bsky.social
November 3, 2026 at 9:25 PM
ENCIRCLE: Patients with symptomatic mitral regurgitation (MR) who underwent full percutaneous transseptal #TMVR continued to see durable near #vhdMR elimination & sustained improvements in functional & health status outcomes at 2 years. https://bit.ly/4z2BMIW
#JACC #CardioSky @crfheart.bsky.social
#JACC #CardioSky @crfheart.bsky.social
#TCT2026: The JENA-VAD study simultaneously published in #JACC sheds early light on #TAVR using the Trilogy transcatheter heart valve for left ventricular assist device (LVAD)-associated aortic regurgitation.
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
November 3, 2026 at 10:00 PM
#TCT2026: The JENA-VAD study simultaneously published in #JACC sheds early light on #TAVR using the Trilogy transcatheter heart valve for left ventricular assist device (LVAD)-associated aortic regurgitation.
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
#TCT2026 IRIS-MAIN: No statistically significant difference in long-term all-cause mortality was observed among Asian patients with unprotected left main coronary artery disease who underwent #PCI or #CABG.
🔗 https://bit.ly/4zsuPC7 #cvCAD #CardioSky
🔗 https://bit.ly/4zsuPC7 #cvCAD #CardioSky
November 3, 2026 at 8:30 PM
#TCT2026 IRIS-MAIN: No statistically significant difference in long-term all-cause mortality was observed among Asian patients with unprotected left main coronary artery disease who underwent #PCI or #CABG.
🔗 https://bit.ly/4zsuPC7 #cvCAD #CardioSky
🔗 https://bit.ly/4zsuPC7 #cvCAD #CardioSky
Results from the SPYRAL AFFIRM study presented at #TCT2026: Radiofrequency renal denervation (RDN) utilizing the Symplicity Spyral device may effectively lower in-office systolic blood pressure (BP) at six months.
Follow ACC's Meeting Coverage ➡️ https://bit.ly/4jVHEjt #CardioSky
Follow ACC's Meeting Coverage ➡️ https://bit.ly/4jVHEjt #CardioSky
November 3, 2026 at 8:05 PM
Results from the SPYRAL AFFIRM study presented at #TCT2026: Radiofrequency renal denervation (RDN) utilizing the Symplicity Spyral device may effectively lower in-office systolic blood pressure (BP) at six months.
Follow ACC's Meeting Coverage ➡️ https://bit.ly/4jVHEjt #CardioSky
Follow ACC's Meeting Coverage ➡️ https://bit.ly/4jVHEjt #CardioSky
📹 Hear from Jennifer Rymer, MD, FACC, member of #ACCEarlyCareer Membership Section Leadership Council, as she highlights LBCS from Day 3️⃣ of #TCT2026 and shares key insights from 👇
✅ AIR STEMI
✅ TomorrowLAND
✅ SIRONA
Learn more about the trials ➡️ https://bit.ly/4iuTCy6 #CardioSky
✅ AIR STEMI
✅ TomorrowLAND
✅ SIRONA
Learn more about the trials ➡️ https://bit.ly/4iuTCy6 #CardioSky
November 3, 2026 at 1:15 AM
📹 Hear from Jennifer Rymer, MD, FACC, member of #ACCEarlyCareer Membership Section Leadership Council, as she highlights LBCS from Day 3️⃣ of #TCT2026 and shares key insights from 👇
✅ AIR STEMI
✅ TomorrowLAND
✅ SIRONA
Learn more about the trials ➡️ https://bit.ly/4iuTCy6 #CardioSky
✅ AIR STEMI
✅ TomorrowLAND
✅ SIRONA
Learn more about the trials ➡️ https://bit.ly/4iuTCy6 #CardioSky
Noninferiority of angiography-derived fractional flow reserve (angio-FFR) was not met when compared to usual care in patients undergoing #PCI, according to results of the PIONEER IV trial, presented at #TCT2026.
Find out more: https://bit.ly/4iWhWKz #CardioSky
Find out more: https://bit.ly/4iWhWKz #CardioSky
November 3, 2026 at 7:54 PM
Noninferiority of angiography-derived fractional flow reserve (angio-FFR) was not met when compared to usual care in patients undergoing #PCI, according to results of the PIONEER IV trial, presented at #TCT2026.
Find out more: https://bit.ly/4iWhWKz #CardioSky
Find out more: https://bit.ly/4iWhWKz #CardioSky
“We want to uncouple procedural competency and volume from medical knowledge competency.”
At #TCT2026 SCAI President J. Dawn Abbott, MD, MSCAI, urged ABIM to end certification volume requirements and assess procedural competence through credentialing, peer review and outcomes assessment. #CardioSky
At #TCT2026 SCAI President J. Dawn Abbott, MD, MSCAI, urged ABIM to end certification volume requirements and assess procedural competence through credentialing, peer review and outcomes assessment. #CardioSky
November 3, 2026 at 9:35 PM
“We want to uncouple procedural competency and volume from medical knowledge competency.”
At #TCT2026 SCAI President J. Dawn Abbott, MD, MSCAI, urged ABIM to end certification volume requirements and assess procedural competence through credentialing, peer review and outcomes assessment. #CardioSky
At #TCT2026 SCAI President J. Dawn Abbott, MD, MSCAI, urged ABIM to end certification volume requirements and assess procedural competence through credentialing, peer review and outcomes assessment. #CardioSky
🤖 KI in der #Kardiologie: Hype vs. Realität. Was kann #KI heute schon im Klinikalltag leisten?🎙️ A. Idris spricht im neuen #YoungDGK Podcast mit Dr. A. Freund & Dr. S. Feickert u.a. über den EU AI Act.
🎧 Jetzt reinhören:
➡️ herzmedizin.de/fuer-...
#DGK #CardioSky
🎧 Jetzt reinhören:
➡️ herzmedizin.de/fuer-...
#DGK #CardioSky
November 2, 2026 at 3:44 PM
🤖 KI in der #Kardiologie: Hype vs. Realität. Was kann #KI heute schon im Klinikalltag leisten?🎙️ A. Idris spricht im neuen #YoungDGK Podcast mit Dr. A. Freund & Dr. S. Feickert u.a. über den EU AI Act.
🎧 Jetzt reinhören:
➡️ herzmedizin.de/fuer-...
#DGK #CardioSky
🎧 Jetzt reinhören:
➡️ herzmedizin.de/fuer-...
#DGK #CardioSky
#TCT2026: TRAVEL III, found that transjugular transcatheter tricuspid valve replacement (TTVR) with the new LuX-Valve Plus system in addition to optimal medical therapy (OMT) was superior to OMT alone in reducing tricuspid regurgitation.
🔗 https://bit.ly/4zg40AS #vhdTR #CardioSky
🔗 https://bit.ly/4zg40AS #vhdTR #CardioSky
November 2, 2026 at 12:35 AM
#TCT2026: TRAVEL III, found that transjugular transcatheter tricuspid valve replacement (TTVR) with the new LuX-Valve Plus system in addition to optimal medical therapy (OMT) was superior to OMT alone in reducing tricuspid regurgitation.
🔗 https://bit.ly/4zg40AS #vhdTR #CardioSky
🔗 https://bit.ly/4zg40AS #vhdTR #CardioSky
Well, Cardiosky looks very useful. I may not be a specialist in this realm, but I have a mechanical heart valve, so I am happy to promote this!
Wow, how #cardiosky has grown!
Our first starter pack is already full, see if you've missed anyone: go.bsky.app/562nfhZ
Our first starter pack is already full, see if you've missed anyone: go.bsky.app/562nfhZ
October 30, 2026 at 12:08 PM
Well, Cardiosky looks very useful. I may not be a specialist in this realm, but I have a mechanical heart valve, so I am happy to promote this!
Hear from Drs. John A. Spertus, Rasha Al-Lamee, & John Bittl as they discuss the highlights from Day 2️⃣ of #TCT2026 & preview what's ahead on Day 3️⃣, including the simultaneous publication of LBCTs in #JACC!
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky
November 2, 2026 at 5:23 PM
Hear from Drs. John A. Spertus, Rasha Al-Lamee, & John Bittl as they discuss the highlights from Day 2️⃣ of #TCT2026 & preview what's ahead on Day 3️⃣, including the simultaneous publication of LBCTs in #JACC!
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky